Differenzialdiagnose der linksventrikulären Funktionsstörungen ohne Late Gadolinium Enhancement

Die MRT-Bildgebung hat in der Diagnostik von Herzerkrankungen große Fortschritte gemacht und kann Myokardinfarkte oder eine Myokarditis durch die Kombination von Wandbewegungsanalyse, Kontrastmittelanreicherung und Ödem zuverlässig nachweisen und differenzieren. Die Differenzialdiagnose von linksventrikulären Funktionsstörungen ohne Late Gadolinium Enhancement bleibt aber eine Herausforderung; oft sind zusätzlich klinische Informationen erforderlich.

Schlüsselwörter

Linksventrikuläre Funktionsstörungen - dilatative Kardiomyopathie - Tako-Tsubo-Kardiomyopathie - peripartale Kardiomyopathie - Tachykardiomyopathie

• Literatur

• 1 Arora NP, Mohamad T, Mahajan N. et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy. Am J Med Sci 2014; 347: 112-117
• 2 Bossone E, Lyon A, Citro R. et al. Takotsubo cardiomyopathy: an integrated multi-imaging approach. Eur Heart J Cardiovasc Imaging 2014; 15: 366-377
• 3 Bouabdallaoui N, Mouquet F, Lebreton G. et al. Current knowledge and recent development on management of peripartum cardiomyopathy. Eur Heart J Acute Cardiovasc Care 2017; 6: 359-366
• 4 Dastidar AG, Frontera A, Palazzuoli A. et al. TakoTsubo cardiomyopathy: unravelling the malignant consequences of a benign disease with cardiac magnetic resonance. Heart Fail Rev 2015; 20: 415-421
• 5 Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P. et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA 2011; 306: 277-286
• 6 Ghadri JR, Ruschitzka F, Lüscher TF. et al. Takotsubo cardiomyopathy: still much more to learn. Heart 2014; 100: 1804-1812
• 7 Hasdemir C, Yuksel A, Camli D. et al. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol 2012; 35: 465-470
• 8 Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 2014; 11: 364-370
• 9 Hilfiker-Kleiner D, Bauersachs J. Herzerkrankungen in der Schwangerschaft. Dtsch Med Wochenschr 2016; 141: 110-114
• 10 Holmström M, Kivistö S, Heliö T. et al. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy. J Cardiovasc Magn Reson 2011; 13: 30
• 11 Khan R, Massel D, Stirrat J. et al. Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study. Int J Cardiovasc Imaging 2013; 29: 395-404
• 12 Lehrke S, Lossnitzer D, Schöb M. et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 727-732
• 13 Leyva F, Taylor RJ, Foley PW. et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 2012; 60: 1659-1667
• 14 Lishmanov A, Chockalingam P, Senthilkumar A. et al. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail 2010; 16: 122-126
• 15 Machii M, Satoh H, Shiraki K. et al. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome. Magn Reson Imaging 2014; 32: 118-124
• 16 Marchal P, Lairez O, Cognet T. et al. Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study. Eur Heart J Cardiovasc Imaging 2013; 14: 914-920
• 17 Morris PD, Robinson T, Channer KS. Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities. Postgrad Med J 2012; 88: 706-712
• 18 Neil C, Nguyen TH, Kucia A. et al. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart 2012; 98: 1278-1284
• 19 Patel H, Madanieh R, Kosmas CE. et al. Reversible cardiomyopathies. Clin Med Insights Cardiol 2015; 21(9 Suppl.2): 7-14
• 20 Pathik B, Raman B, Mohd Amin NH. et al. Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2016; 17: 1146-1152 doi:10.1093/ehjci/jev289
• 21 Rapezzi C, Arbustini E, Caforio AL. et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34 (19) 1448-1458
• 22 Renz DM, Röttgen R, Habedank D. et al. Neue Erkenntnisse der peripartalen Kardiomyopathie durch die Magnetresonanztomografie des Herzens. Fortschr Röntgenstr 2011; 183: 834-841
• 23 Siepen F, Buss SJ, Messroghli D. et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015; 16: 210-216
• 24 Voigt A, Elgeti T, Durmus T. et al. Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults – towards identification of myocardial inflammation. Eur Radiol 2011; 21: 925-935
• 25 Ware JS, Li J, Mazaika E. et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 2016; 374: 233-241
• 26 Yamada T, Hirashiki A, Cheng XW. et al. Relationship of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic dilated cardiomyopathy – a comparison of focal and interstitial fibrosis. J Card Fail 2013; 19: 557-564